{"id":523,"date":"2023-10-04T19:33:48","date_gmt":"2023-10-04T19:33:48","guid":{"rendered":"https:\/\/vigilantbiosciences.com\/?p=523"},"modified":"2023-10-11T19:35:24","modified_gmt":"2023-10-11T19:35:24","slug":"bevigilant-orafusion-system-released-in-italy","status":"publish","type":"post","link":"https:\/\/vigilantbiosciences.com\/fr\/systeme-dorafusion-vigilant-lance-en-italie\/","title":{"rendered":"Le syst\u00e8me BeVigilant\u2122 OraFusion\u2122 est lanc\u00e9 en Italie"},"content":{"rendered":"

[et_pb_section fb_built=\u201d1\u2033 _builder_version=\u201d4.16\u2033 verrouill\u00e9=\u201doff\u201d global_colors_info=\u201d{}\u201d][et_pb_row _builder_version=\u201d4.16\u2033 background_size=\u201dinitial\u201d background_position=\u201dtop_left\u201d background_repeat=\u201drepeat\u201d global_colors_info=\u201d{ }\u201d][et_pb_column type=\u201d4_4\u2033 _builder_version=\u201d4.16\u2033 custom_padding=\u201d|||\u201d global_colors_info=\u201d{}\u201d custom_padding__hover=\u201d|||\u201d][et_pb_text _builder_version=\u201d4.22.2\u2033 header_2_font_size=\u201d24px\u201d header_2_line_height=\u201d1.4em\u201d background_size=\u201dinitial\u201d background_position=\u201dtop_left\u201d background_repeat=\u201drepeat\u201d custom_padding =\u201d25px||||false|false\u201d global_colors_info=\u201d{}\u201d]<\/p>\n

Vigilant Biosciences\u00ae m\u00e8ne la charge contre le cancer de la bouche<\/h2>\n

Lakeway, Texas (4 octobre 2023) \u2013 Vigilant Biosciences\u00ae, Inc. (\u00ab Vigilant \u00bb), un d\u00e9veloppeur leader de solutions de pointe qui acc\u00e9l\u00e8rent la d\u00e9tection du cancer de la bouche, annonce le lancement de son produit phare, le BeVigilant\u2122. Syst\u00e8me OraFusion\u2122, en Italie. <\/p>\n

Le syst\u00e8me BeVigilant\u2122 OraFusion\u2122 est un dispositif r\u00e9volutionnaire qui administre une \u00e9valuation du risque de cancer de la bouche au point de service. Le syst\u00e8me fournit un r\u00e9sultat pr\u00e9cis d'\u00e9valuation des risques gr\u00e2ce \u00e0 l'analyse combin\u00e9e des concentrations de biomarqueurs \u00e0 un stade pr\u00e9coce et \u00e0 une \u00e9valuation intelligente des facteurs de risque cliniques aliment\u00e9e par un logiciel. Cette analyse int\u00e9gr\u00e9e fournit aux cliniciens de premi\u00e8re ligne les donn\u00e9es n\u00e9cessaires pour prendre des d\u00e9cisions th\u00e9rapeutiques \u00e9clair\u00e9es pour les patients pr\u00e9sentant des l\u00e9sions buccales.<\/p>\n

\u00ab\u00a0Depuis le d\u00e9but, Vigilant a pour objectif d'augmenter le taux de survie au cancer de la bouche gr\u00e2ce \u00e0 une d\u00e9tection et une intervention pr\u00e9coces\u00a0\u00bb, a d\u00e9clar\u00e9 Bill Brodie, PDG de Vigilant Biosciences\u00ae. \u00ab Le syst\u00e8me BeVigilant\u2122 OraFusion\u2122 permet de r\u00e9aliser cet objectif, en aidant les cliniciens dans l'\u00e9valuation du cancer de la bouche \u00e0 le d\u00e9tecter plus t\u00f4t que jamais. En franchissant la prochaine \u00e9tape dans la refonte de la d\u00e9tection du cancer de la bouche, nous pensons que notre technologie apportera de l\u2019espoir et des r\u00e9sultats salvateurs aux personnes touch\u00e9es par cette maladie.<\/p>\n

Lorsque les patients sont orient\u00e9s vers des soins sp\u00e9cialis\u00e9s au cours des premiers stades du cancer de la bouche, le traitement est souvent moins invasif et plus efficace, ce qui conduit \u00e0 des r\u00e9sultats consid\u00e9rablement am\u00e9lior\u00e9s. Le taux de survie actuel du cancer de la bouche est de 50%, mais une d\u00e9tection pr\u00e9coce peut augmenter consid\u00e9rablement le taux de survie jusqu'\u00e0 90%. <\/p>\n

Vigilant Biosciences\u00ae continue d'ouvrir la voie dans la lutte contre le cancer de la bouche avec des solutions simples, pr\u00e9cises et rentables qui permettent une d\u00e9tection pr\u00e9coce, une intervention efficace et de meilleurs r\u00e9sultats. Pour plus d'informations sur Vigilant Biosciences\u00ae et ses produits, veuillez visiter https:\/\/vigilantbiosciences.com\/<\/a>. <\/p>\n

Remarque\u00a0: Le syst\u00e8me BeVigilant\u2122 OraFusion\u2122 n'est pas disponible \u00e0 la vente aux \u00c9tats-Unis.<\/p>\n

\u00c0 propos de Vigilant Biosciences\u00ae, Inc.<\/strong>
\nVigilant Biosciences\u00ae est un innovateur et d\u00e9veloppeur de premier plan de solutions qui aident les cliniciens \u00e0 d\u00e9tecter pr\u00e9cocement le cancer de la bouche. La gamme de produits BeVigilant\u2122 de Vigilant comprend des tests au point d'intervention qui sont simples, pr\u00e9cis et rentables, permettant aux professionnels de la sant\u00e9 d'am\u00e9liorer la vie gr\u00e2ce \u00e0 une intervention plus pr\u00e9coce. Apprenez-en davantage sur les biosciences vigilantes sur https:\/\/vigilantbiosciences.com\/<\/a>.[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>","protected":false},"excerpt":{"rendered":"

Vigilant Biosciences\u00ae m\u00e8ne la charge contre le cancer de la bouche Lakeway, Texas (4 octobre 2023) \u2013 Vigilant Biosciences\u00ae, Inc. (\u00ab Vigilant \u00bb), un d\u00e9veloppeur leader de solutions de pointe qui acc\u00e9l\u00e8rent la d\u00e9tection du cancer de la bouche, annonce le lancement de son produit phare, le syst\u00e8me BeVigilant\u2122 OraFusion\u2122, en Italie. Le syst\u00e8me BeVigilant\u2122 OraFusion\u2122 est un dispositif r\u00e9volutionnaire qui administre un [\u2026]<\/p>","protected":false},"author":3,"featured_media":527,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-523","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"\nBeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae<\/title>\n<meta name=\"description\" content=\"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vigilantbiosciences.com\/fr\/systeme-dorafusion-vigilant-lance-en-italie\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae\" \/>\n<meta property=\"og:description\" content=\"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vigilantbiosciences.com\/fr\/systeme-dorafusion-vigilant-lance-en-italie\/\" \/>\n<meta property=\"og:site_name\" content=\"Vigilant Biosciences\u00ae\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/VigilantBiosciences1\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-04T19:33:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-11T19:35:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/dentist-with-patient-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"dex.manley\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"dex.manley\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\"},\"author\":{\"name\":\"dex.manley\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357\"},\"headline\":\"BeVigilant\u2122 OraFusion\u2122 System Released in Italy\",\"datePublished\":\"2023-10-04T19:33:48+00:00\",\"dateModified\":\"2023-10-11T19:35:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\"},\"wordCount\":431,\"publisher\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\",\"url\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\",\"name\":\"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae\",\"isPartOf\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#website\"},\"datePublished\":\"2023-10-04T19:33:48+00:00\",\"dateModified\":\"2023-10-11T19:35:24+00:00\",\"description\":\"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.\",\"breadcrumb\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/vigilantbiosciences.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BeVigilant\u2122 OraFusion\u2122 System Released in Italy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#website\",\"url\":\"https:\/\/vigilantbiosciences.com\/\",\"name\":\"Vigilant Biosciences\u00ae\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/vigilantbiosciences.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\",\"name\":\"Vigilant Biosciences\u00ae\",\"url\":\"https:\/\/vigilantbiosciences.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg\",\"contentUrl\":\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg\",\"width\":\"1024\",\"height\":\"1024\",\"caption\":\"Vigilant Biosciences\u00ae\"},\"image\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/VigilantBiosciences1\",\"https:\/\/www.linkedin.com\/company\/vigilant-biosciences\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357\",\"name\":\"dex.manley\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g\",\"caption\":\"dex.manley\"},\"url\":\"https:\/\/vigilantbiosciences.com\/fr\/author\/dex-manley\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae","description":"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vigilantbiosciences.com\/fr\/systeme-dorafusion-vigilant-lance-en-italie\/","og_locale":"fr_FR","og_type":"article","og_title":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae","og_description":"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.","og_url":"https:\/\/vigilantbiosciences.com\/fr\/systeme-dorafusion-vigilant-lance-en-italie\/","og_site_name":"Vigilant Biosciences\u00ae","article_publisher":"https:\/\/www.facebook.com\/VigilantBiosciences1","article_published_time":"2023-10-04T19:33:48+00:00","article_modified_time":"2023-10-11T19:35:24+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/dentist-with-patient-1.jpg","type":"image\/jpeg"}],"author":"dex.manley","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"dex.manley","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#article","isPartOf":{"@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/"},"author":{"name":"dex.manley","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357"},"headline":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy","datePublished":"2023-10-04T19:33:48+00:00","dateModified":"2023-10-11T19:35:24+00:00","mainEntityOfPage":{"@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/"},"wordCount":431,"publisher":{"@id":"https:\/\/vigilantbiosciences.com\/#organization"},"articleSection":["News"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/","url":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/","name":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae","isPartOf":{"@id":"https:\/\/vigilantbiosciences.com\/#website"},"datePublished":"2023-10-04T19:33:48+00:00","dateModified":"2023-10-11T19:35:24+00:00","description":"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.","breadcrumb":{"@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/vigilantbiosciences.com\/"},{"@type":"ListItem","position":2,"name":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy"}]},{"@type":"WebSite","@id":"https:\/\/vigilantbiosciences.com\/#website","url":"https:\/\/vigilantbiosciences.com\/","name":"Vigilant Biosciences\u00ae","description":"","publisher":{"@id":"https:\/\/vigilantbiosciences.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vigilantbiosciences.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/vigilantbiosciences.com\/#organization","name":"Vigilant Biosciences\u00ae","url":"https:\/\/vigilantbiosciences.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/","url":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg","contentUrl":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg","width":"1024","height":"1024","caption":"Vigilant Biosciences\u00ae"},"image":{"@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/VigilantBiosciences1","https:\/\/www.linkedin.com\/company\/vigilant-biosciences\/"]},{"@type":"Person","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357","name":"dex.manley","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g","caption":"dex.manley"},"url":"https:\/\/vigilantbiosciences.com\/fr\/author\/dex-manley\/"}]}},"_links":{"self":[{"href":"https:\/\/vigilantbiosciences.com\/fr\/wp-json\/wp\/v2\/posts\/523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vigilantbiosciences.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vigilantbiosciences.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/fr\/wp-json\/wp\/v2\/comments?post=523"}],"version-history":[{"count":0,"href":"https:\/\/vigilantbiosciences.com\/fr\/wp-json\/wp\/v2\/posts\/523\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/fr\/wp-json\/wp\/v2\/media\/527"}],"wp:attachment":[{"href":"https:\/\/vigilantbiosciences.com\/fr\/wp-json\/wp\/v2\/media?parent=523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/fr\/wp-json\/wp\/v2\/categories?post=523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/fr\/wp-json\/wp\/v2\/tags?post=523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}